Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT01581034
Eligibility Criteria:
Inclusion Criteria:
* Male patient with coronary artery disease
* Stable medication
* Physically stable
* Psychologically stable
* Written informed consent
* Willing and able to comply with all trial requirements
* Must have completed rehabilitation program since at least 6 months and no longer than 5 years prior to study begin
Exclusion Criteria:
* Acute coronary syndrome within the last three months
* Abnormal high hepatic enzymes
* Renal insufficiency with compensated retention
* Intake of medication which may affect endothelial function
* Currently smoking
* Current malignant diseases, which may reduce the expectancy of life
* Chronic heart failure
* Insulin-dependent diabetes
* Known hypersensitivity against any ingredient of PADMA 28
* Longterm intake of supplements
* Serious mental health issues
* Alcohol and/or drug abuse
* Simultaneous participation in another clinical trial
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT01581034
Study Brief:
Protocol Section:
NCT01581034